FDA warns about counterfeit versions of diabetes drug Ozempic

A pharmacist displays boxes of Ozempic, a drug used for treating type 2 diabetes and obesity made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. [Reuters]

The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's diabetes drug Ozempic that have been found in the country's drug supply chain.

The health regulator said that it would continue to investigate counterfeit Ozempic 1-milligram injections and had seized thousands of units, but that some might still be available for purchase.